In summary, there are a broad array of gene-editing techniques available to correct many CF-causing variants simultaneously using superexon donors or targeted integration of the complete CFTR cDNA, or both gene and base editing techniques that could be used to precisely repair individual CF-causing variants. Here, CFTR is linked to cystic fibrosis.